These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32772271)

  • 81. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
    Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM
    Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586
    [TBL] [Abstract][Full Text] [Related]  

  • 82. PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway.
    Shi M; Cao M; Song J; Liu Q; Li H; Meng F; Pan Z; Bai J; Zheng J
    Mol Cancer; 2015 Mar; 14():66. PubMed ID: 25888829
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Targeting of miR9/NOTCH1 interaction reduces metastatic behavior in triple-negative breast cancer.
    Mohammadi-Yeganeh S; Mansouri A; Paryan M
    Chem Biol Drug Des; 2015 Nov; 86(5):1185-91. PubMed ID: 25963903
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Paeoniflorin influences breast cancer cell proliferation and invasion via inhibition of the Notch‑1 signaling pathway.
    Zhang J; Yu K; Han X; Zhen L; Liu M; Zhang X; Ren Y; Shi J
    Mol Med Rep; 2018 Jan; 17(1):1321-1325. PubMed ID: 29115554
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer.
    Seachrist DD; Sizemore ST; Johnson E; Abdul-Karim FW; Weber Bonk KL; Keri RA
    Breast Cancer Res; 2017 Jun; 19(1):66. PubMed ID: 28583174
    [TBL] [Abstract][Full Text] [Related]  

  • 86. MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
    Sui Y; Zhang X; Yang H; Wei W; Wang M
    Oncol Rep; 2018 Feb; 39(2):473-482. PubMed ID: 29207145
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
    Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S
    Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529
    [TBL] [Abstract][Full Text] [Related]  

  • 88. miR-30a inhibits the biological function of breast cancer cells by targeting Notch1.
    Zhang HD; Jiang LH; Sun DW; Li J; Tang JH
    Int J Mol Med; 2017 Oct; 40(4):1235-1242. PubMed ID: 28765900
    [TBL] [Abstract][Full Text] [Related]  

  • 89. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
    Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer.
    Li Y; Su X; Pan H
    Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011
    [TBL] [Abstract][Full Text] [Related]  

  • 91. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
    Sun WM; Tao W; Li JC; Zhu DM; Miao Y
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Ezrin accelerates breast cancer liver metastasis through promoting furin-like convertase-mediated cleavage of Notch1.
    Chen M; Pan Y; Liu H; Ning F; Lu Q; Duan Y; Gan X; Lu S; Hou H; Zhang M; Tian Y; Lash GE
    Cell Oncol (Dordr); 2023 Jun; 46(3):571-587. PubMed ID: 36580262
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients.
    Chen YL; Lee KT; Wang CY; Shen CH; Chen SC; Chung WP; Hsu YT; Kuo YL; Chen PS; Cheung CHA; Chang CP; Shen MR; Hsu HP
    Am J Cancer Res; 2022; 12(5):2084-2101. PubMed ID: 35693094
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Retraction: Btbd7 is essential for region-specific epithelial cell dynamics and branching morphogenesis
    Daley WP; Matsumoto K; Doyle AD; Wang S; DuChez BJ; Holmbeck K; Yamada KM
    Development; 2020 Aug; 147(15):. PubMed ID: 32792339
    [No Abstract]   [Full Text] [Related]  

  • 95. BTB protein family and human breast cancer: signaling pathways and clinical progress.
    Zhang H; Ouyang C
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):16213-16229. PubMed ID: 37682360
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms.
    Rezaee M; Mohammadi F; Keshavarzmotamed A; Yahyazadeh S; Vakili O; Milasi YE; Veisi V; Dehmordi RM; Asadi S; Ghorbanhosseini SS; Rostami M; Alimohammadi M; Azadi A; Moussavi N; Asemi Z; Aminianfar A; Mirzaei H; Mafi A
    Front Pharmacol; 2023; 14():1152672. PubMed ID: 37153758
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The Role of BTBD7 in Normal Development and Tumor Progression.
    Liu Y; Song J; Gu J; Xu S; Wang X; Liu Y
    Technol Cancer Res Treat; 2023; 22():15330338231167732. PubMed ID: 37050886
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Extracellular Vesicles Carrying miR-887-3p Promote Breast Cancer Cell Drug Resistance by Targeting BTBD7 and Activating the Notch1/Hes1 Signaling Pathway.
    Wang B; Wang Y; Wang X; Gu J; Wu W; Wu H; Wang Q; Zhou D
    Dis Markers; 2022; 2022():5762686. PubMed ID: 35655918
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.